Healthcare

The departure comes as the heavily-backed telehealth company navigates growing pains at home and focuses on stability and overseas expansion.

Main Sequence has recruited three healthcare specialists and hopes to expand investments across therapeutics, diagnostics, devices and digital health, with a particular focus on women's health.

Apple Intelligence is widely seen as the company’s next major growth engine, but it’s not the only significant bet the iPhone maker is placing.

The Eucalyptus CEO has explained why the company suddenly pulled its much-hyped men's longevity product off the market — and what it has planned for its relaunch.

The ambitious longevity health play will be rebuilt as Australia's most recognisable health startup looks to address 'key gaps'.